PHIM Responsive Header

Category: Latest News and Events

  • IDSR Epidemiological Bulletin – Week 21.

    IDSR Epidemiological Bulletin – Week 21.

    IDSR Bulletin Dashboard – Week 21, 2026

    Weekly IDSR Bulletin

    Epidemiological Week 21 (18-24 May, 2026)

    Status: Official Release Published: May 30, 2026

    Editorial Team

    Dr. Matthews Kagoli
    Mrs. Flora Dimba
    Mr. Settie Kanyanda
    Mr. Austin Zgambo
    Mr. Selemani Ngwira
    Mr. James Jere
    Mr. Vincent Kamforzi
    Mr. Noel Khunga
    COMPLETENESS
    95.6%
    TIMELINESS
    95.1%
    MALARIA
    37,499
    EBS SIGNALS
    104
    TYPHOID
    113
    CHOLERA (S)
    149

    I. Performance & Surveillance

    Reporting Completeness & Timeliness Analysis

    Detailed Bulletin Analysis

    The national reporting performance for Epidemiological Week 21 has achieved a highly positive trajectory, registering 95.6% for reporting completeness and an outstanding 95.1% for reporting timeliness on the One Health Surveillance Platform (OHSP). This performance demonstrates the robust capacity of our integrated tracking systems to capture facility data with minimal informational latency. Out of the 33 designated national reporting sites, all health zones successfully met the minimum target of 80% for both completeness and timeliness. This widespread platform adoption provides public health decision-makers with real-time situational awareness across the territory.

    When evaluated against the previous historical baseline in Epidemiological Week 20, which achieved 95.0% completeness and 94.0% timeliness, Week 21 displays a general improvement across both surveillance domains. Completeness rose by 0.6 percentage points, while timeliness climbed by 1.1 percentage points. This positive trend was primarily anchored by Central Hospitals (100.0% on both metrics) and the Central West and South West Zones. However, administrative delays persist at the district level: Balaka DHO (72.0% completeness and timeliness) and Karonga DHO (61.0% completeness and 57.0% timeliness) both failed to meet the critical 80% threshold, presenting minor tracking blind spots.

    To address these remaining gaps and maintain optimal surveillance parameters, the National IDSR Secretariat recommends immediate administrative follow-up. Balaka, Karonga, Dowa, and Zomba DHOs must prioritize targeted administrative interventions to resolve database entry delays. IDSR coordinators and Zonal Epidemiology Officers must ensure timely verification and validation of clinical data immediately after facility focal points submit weekly forms to safeguard platform responsiveness during active outbreaks.

    II. Disease Morbidity

    Malaria Morbidity & Mortality

    Detailed Bulletin Analysis

    Malaria remains the dominant priority clinical condition under active surveillance in Malawi, with Epidemiological Week 21 recording an immense burden of 37,499 cases (37,059 OPD and 440 IPD) alongside 4 associated inpatient deaths. This heavy volume of clinical cases indicates intense transmission dynamics, placing constant pressure on primary care facilities, diagnostic laboratories, and essential antimalarial drug inventories. High-burden districts like Blantyre (4,069 cases), Mangochi (3,155 cases), and Chikwawa (3,023 cases) continue to represent key transmission hotspots requiring sustained public health intervention.

    When contrasted with the previous baseline in Epidemiological Week 20, the malaria data reveals an upward trajectory in morbidity but a positive decline in inpatient mortality. Total malaria cases rose by 8.3%, surging from 34,625 cases in Week 20 to 37,499 cases in Week 21. Conversely, confirmed inpatient deaths decreased by 50.0%, falling from 8 down to 4. This synchronous drop in fatal outcomes suggests improving clinical therapeutic timing and supportive inpatient protocols, even as environmental factors support vector propagation across high-burden districts.

    To address this rising transmission trend, the National Malaria Control Program must coordinate immediate antimalarial supply chain audits to ensure uninterrupted buffer stocks of Artemisinin-based Combination Therapy (ACTs) and Rapid Diagnostic Tests (RDTs). Clinical teams must conduct rigorous mortality audits on the 4 recorded deaths to identify systemic or clinical delays in administering intravenous artesunate. Concurrently, Health Surveillance Assistants (HSAs) must scale up risk communication campaigns to emphasize immediate care-seeking behaviors for all febrile illnesses.

    Enteric Diseases (Typhoid & Diarrhoea)

    Detailed Bulletin Analysis

    The surveillance of waterborne enteric pathogens in Epidemiological Week 21 has flagged a significant clinical concern, with Typhoid fever cases recorded at 113 (99 OPD and 14 IPD) and Bloody Diarrhoea cases totaling 788. Waterborne disease transmission remains a persistent threat, especially in urban areas with compromised water and sanitation networks. A notable geographic cluster remains centered in Blantyre DHO (51 Typhoid cases) and Lilongwe DHO (18 OPD and 11 IPD Typhoid cases), requiring immediate environmental health investigations to locate potential points of source contamination.

    When compared to the baseline figures from Epidemiological Week 20, the enteric profile shows a mixed trajectory. Bloody Diarrhoea cases remained stable with a minor 0.6% increase, moving from 783 cases to 788 cases. Conversely, Typhoid fever cases experienced a slight 10.3% decline, dropping from 126 down to 113 cases. Despite this nominal national reduction, the severe concentration of Typhoid cases in Blantyre (45.1% of the national burden) indicates that waterborne and foodborne pathogens are actively spreading within specific metropolitan neighborhoods.

    Based on these findings, we recommend that Blantyre, Lilongwe, Mchinji, Kasungu, and Dedza DHOs deploy rapid response teams to conduct systematic water quality monitoring and food safety inspections. Stool and blood cultures must be collected from suspected Typhoid cases to check for potential antimicrobial resistance patterns and guide clinical therapy. Furthermore, environmental health officers must distribute household water treatment chemicals and conduct hygiene sensitization campaigns in high-density markets to break enteric transmission chains.

    III. Critical Alerts & Mortality

    Cholera and Mpox Status

    Detailed Bulletin Analysis

    Epidemiological Week 21 recorded 149 suspected Cholera cases, of which 25 were laboratory-confirmed (or epidemiologically linked) cholera cases, alongside a commendable zero-death record. This stable survival rate reflects the high quality of supportive rehydration and prompt case management within established Cholera Treatment Units (CTUs). On the zoonotic disease front, Mpox surveillance detected 2 suspect alerts, but happily, zero (0) new cases were confirmed, keeping the cumulative national total stable at 157 confirmed cases since the outbreak began in April 2025, with Lilongwe representing 75.8% of cases.

    A comparison with Epidemiological Week 20 shows that the Cholera outbreak is evolving toward a highly concentrated phase with a much higher laboratory-confirmation rate. While the absolute number of suspected cholera cases declined from 255 in Week 17 to 145 in Week 20 and then rose slightly to 149 in Week 21, confirmed cholera cases declined from 84 in Week 20 to 25 in Week 21. This reduction in confirmed cases indicates that transmission is highly concentrated in hotspot districts, particularly Blantyre and Chikwawa. Concurrently, Mpox alerts remained stable at 2, with zero new cases confirmed.

    To counter this growing Cholera threat, the National Incident Management System must continue to direct emergency water, sanitation, and hygiene (WASH) resources to high-incidence hotspots. In addition, CTU inventories of Oral Rehydration Salts (ORS), IV fluids, and rapid cholera tests must be restocked to prevent shortages. While Mpox reported zero confirmed cases, the 2 new alerts must be investigated within 24 hours. Cross-border coordination with Mozambique and Tanzania must also be maintained to make sure any imported cases are detected and managed promptly.

    SARI & Respiratory Mortality

    Detailed Bulletin Analysis

    Severe Acute Respiratory Infections (SARI) presented 129 clinical cases and 2 deaths during Epidemiological Week 21. The severe respiratory burden continues to affect several central districts, with Kamuzu Central Hospital (KCH) in Lilongwe reporting 37 cases and 2 deaths, and Dowa DHO reporting 53 cases. This consistent concentration highlights the need for continuous sentinel respiratory surveillance and clinical preparedness within tertiary facilities to handle sudden influxes of acute respiratory cases.

    When evaluated against the baseline from Epidemiological Week 20, the SARI surveillance data displays a notable decrease in respiratory morbidity but stable mortality. National SARI cases declined by 22.3%, dropping from 166 cases in Week 20 to 129 cases in Week 21, while SARI-associated deaths remained stable at 2. This persistent level of clinical mortality highlights the circulation of seasonal respiratory pathogens, such as Influenza A/B or RSV, requiring immediate diagnostic and clinical attention.

    We recommend that clinical teams at Kamuzu Central Hospital, Dowa District Hospital, and other sentinel hospitals continue to systematically collect nasopharyngeal swabs from SARI patients for PCR diagnostic analysis. Healthcare facilities must ensure that pediatric oxygen delivery systems, clinical nebulizers, and essential respiratory therapeutics remain fully functional. Furthermore, clinicians must continue to document and report SARI cases on the OHSP, allowing public health teams to identify and respond to any new respiratory anomalies quickly.

    IV. Vaccine Preventable Diseases

    Measles & VPD Surveillance Distribution

    Detailed Bulletin Analysis

    Vaccine-Preventable Disease (VPD) surveillance remains a high-priority public health activity, with cumulative confirmed Measles cases rising significantly to 366 across 23 districts in 2026. This week recorded 84 new Measles alerts, emphasizing the persistent transmission risk in hotspot districts, with Balaka reporting the highest proportion at 21.9% (80 cumulative cases). Under the IDSR framework, Acute Flaccid Paralysis (AFP) surveillance recorded 6 cases, and Meningococcal meningitis recorded 26 cases, highlighting the need for sustained immunization coverage and active case searching.

    When compared to Epidemiological Week 20, the VPD surveillance profile displays a highly concerning escalation in Meningococcal meningitis and AFP. While weekly Measles alerts declined from 108 cases in Week 20 to 84 cases in Week 21, the cumulative confirmed Measles cases remained stable. Conversely, weekly AFP alerts doubled from 3 in Week 20 to 6 in Week 21, reflecting high surveillance sensitivity. Most significantly, suspected Meningococcal meningitis cases experienced a sharp surge, jumping from 7 cases in Week 20 to 26 cases in Week 21, demanding immediate laboratory investigation.

    We recommend that the Expanded Programme on Immunisation (EPI) immediately schedules targeted supplemental immunization activities (SIA) in Balaka and other high-burden districts to interrupt Measles transmission. For the 6 reported AFP cases, district coordinators must ensure that dual stool samples are collected and sent to the laboratory under strict cold chain conditions. To prevent further Meningococcal meningitis spread, healthcare facilities must strengthen routine surveillance, prioritize lumbar punctures for suspected cases, and ensure immediate diagnostic sample collection.

    V. Summary of Recommendations

    1. Reporting Quality & District Targets

    Balaka, Dowa, Karonga, and Zomba DHOs must implement immediate data validation procedures to improve completeness and timeliness back to target levels of 80% or greater, with Zonal Officers verifying data immediately within the OHSP platform.

    2. Signal Verification & Risk Assessment

    All districts should strengthen the recording and reporting of community-reported Event-Based Surveillance (EBS) signals in OHSP. District Rapid Response Teams (DRRTs) must conduct rapid risk assessments for all verified signals without delay.

    3. AEFI Safety Investigation

    Mzimba North DHO is directed to perform a detailed vaccine safety investigation on the 52 reported Adverse Events Following Immunization (AEFI) to maintain high community trust in routine childhood immunizations.

    Official Documentation

    Access the full PDF bulletin for Epidemiological Week 21, 2026, including detailed district-level performance tables and annexes.

    Authored & Published By

    Moses Nyambalo Phiri

    Public Health Institute of Malawi

    Ministry of Health, Republic of Malawi

  • Webinar on Malaria Genomics and Quality Assurance in Malawi.

    Webinar on Malaria Genomics and Quality Assurance in Malawi.

    WEBINAR ON | PHIM Malawi
    Malaria Genomics & Quality Assurance

    Webinar on Malaria Genomics
    & Quality Assurance

    Strengthening national diagnostic and surveillance precision across Malawi. Learn about high-fidelity genome sequencing techniques, advanced data integration protocols, and laboratory quality management systems.

    Date & Time

    Wed, 10 Jun | 2 PM – 3 PM CAT

    Contributors

    Happy Abraham Manda Christopher Misomali Dr. Mirriam Nyenje

    Keynote Presenters

    Edwin Chitandale

    Edwin Chitandale

    Medical Laboratory Scientist & QMS Expert
    QA Coordinator, PHIM

    Edwin Chitandale serves as the QA Coordinator at PHIM and acts as a QMS consultant to accreditation, continental, regional, and national bodies. He specializes in implementing, training, and auditing complex standards such as ISO 15189, ISO/IEC 17025, and ISO 35001. A recipient of the Zikomo Award of Health Excellence for his COVID-19 response role and a 2024 World Haemophilia Foundation grant, he is currently pursuing his Master in Laboratory Sciences-Haematology.

    Happy Manda

    Happy Manda

    Senior Medical Laboratory Scientist
    National Public Health Laboratory, PHIM

    Happy Manda is a Senior Medical Laboratory Scientist at the Public Health Institute of Malawi, stationed at the National Public Health Laboratory. He specializes in molecular biology diagnostic procedures and target gene sequencing workflows. His research interests focus on tracking drug-resistance mutations in Plasmodium falciparum. He acts as a key facilitator for pathogen surveillance training operations across secondary and tertiary healthcare centers in Malawi.

    Technical Delivery

    Deep dive into lab standards, next-generation malaria genomics data processing, and clinical QMS execution models.

    • Malaria Gene Mutation Tracking
    • ISO Standards Audits (15189, 17025)
    • Statistical Quality Control Validation

    Seminar Program

    Wednesday, 10th June
    02:00 PM

    Welcome & Session Overview

    Introduction to Pathogen Genomics & PHIM Frameworks

    02:10 PM

    Malaria Genomic Sequencing

    Next-Generation Sequencing and Resistance Mapping: Happy Manda

    02:30 PM

    QMS & One Health Audit Standards

    Implementing ISO Standards (15189, 17025) & Method Validation: Edwin Chitandale

    02:50 PM

    Interactive Panel Q&A Session

    Open Floor: Answering Quality Control & Diagnostic Challenges

    Webinar Registration

    Join Happy Manda and Edwin Chitandale for this specialized training session.

    Research & Resources

    Authored & Published By

    Moses Nyambalo Phiri

    Public Health Institute of Malawi

    Ministry of Health, Republic of Malawi

    Building a Healthier Malawi, Together!

  • IDSR Epidemiological Bulletin – Week 20.

    IDSR Epidemiological Bulletin – Week 20.

    IDSR Bulletin Dashboard – Week 20, 2026

    Weekly IDSR Bulletin

    Epidemiological Week 20 (11-17 May, 2026)

    Status: Official Release Published: May 24, 2026

    Editorial Team

    Dr. Matthews Kagoli
    Mr. Seleman Ngwira
    Mr. Austin Zgambo
    Mr. Sikhona Chipeta
    Mr. James Jere
    Mr. Vincent Kamforzi
    COMPLETENESS
    95.0%
    TIMELINESS
    94.0%
    MALARIA
    34,625
    EBS SIGNALS
    78
    TYPHOID
    126
    CHOLERA (S)
    145

    I. Performance & Surveillance

    Reporting Completeness & Timeliness Analysis

    Detailed Bulletin Analysis

    The national reporting performance for Epidemiological Week 20 has achieved a robust trajectory, registering 95.0% for reporting completeness and a highly encouraging 94.0% for reporting timeliness on the One Health Surveillance Platform (OHSP). This commendable performance demonstrates the stable capacity of our national integrated tracking systems to receive and process critical health facility records in a highly timely manner. Across the 33 designated national reporting sites, 29 (87.9%) successfully met the national target of 80% or greater for both completeness and timeliness. This extensive tracking provides the Ministry of Health with real-time situational awareness of priority conditions across the country.

    When evaluated against the previous historical baseline in Epidemiological Week 17, which achieved 97.1% completeness and 91.0% timeliness, Week 20 displays a mixed but highly encouraging evolution. Reporting completeness saw a slight decrease of 2.1 percentage points, declining from 97.1% to 95.0%. However, reporting timeliness experienced a significant increase of 3.0 percentage points, rising from 91.0% to 94.0%. This improvement is especially notable given that Central Hospitals—which previously struggled—achieved a timely submission rate of 75.0% and a completeness rate of 100.0%. However, Zomba, Dowa, and Karonga districts failed to reach target thresholds on both indicators, while Mzuzu Central Hospital fell short specifically on the timeliness metric.

    To address these remaining gaps and maintain optimal surveillance parameters, the National IDSR Secretariat recommends immediate technical follow-up. Zomba, Dowa, and Karonga DHOs must prioritize targeted administrative interventions to resolve local platform connectivity issues and staff reporting delays. In addition, Zonal Epidemiology Officers must enforce daily data validation procedures immediately after facility-level entry, ensuring that delayed reporting sites are supported to achieve the 100% national target for both completeness and timeliness in the upcoming epidemiological cycles.

    II. Disease Morbidity

    Malaria Morbidity & Mortality

    Detailed Bulletin Analysis

    Malaria remains the most significant priority clinical condition under active surveillance in Malawi, with Epidemiological Week 20 recording an immense burden of 34,625 cases and 8 associated inpatient deaths. This heavy volume of clinical cases indicates high transmission dynamics throughout the country and places constant pressure on primary care facilities, diagnostic laboratories, and essential antimalarial drug inventories. The persistent clinical mortality highlights the critical importance of ensuring early diagnosis, immediate therapeutic initiation, and optimal critical care management within inpatient wards nationwide.

    When contrasted with the previous baseline in Epidemiological Week 17, the malaria data reveals a highly concerning upward trajectory in both morbidity and mortality. Total malaria cases rose sharply by 28.4%, surging from 26,959 cases in Week 17 to 34,625 cases in Week 20. Concurrently, confirmed inpatient deaths rose from 6 to 8, representing a 33.3% increase in fatal clinical outcomes. This synchronous climb indicates a expanding vector breeding season or potential gaps in community-level preventative measures (such as bed net usage) and early treatment-seeking behaviors, leading to late clinical presentation with severe complications.

    To address this rising trend, the National Malaria Control Program must coordinate immediate antimalarial supply chain audits. We recommend ensuring that all primary health facilities maintain uninterrupted buffer stocks of Rapid Diagnostic Tests (RDTs) and Artemisinin-based Combination Therapy (ACTs). Clinical teams must conduct rigorous mortality audits on all 8 recorded deaths to determine if there were delays in administering intravenous artesunate. Concurrently, Health Surveillance Assistants (HSAs) must intensify community-level risk communication campaigns to emphasize immediate care-seeking behaviors for all febrile illnesses.

    Enteric Diseases (Typhoid & Diarrhoea)

    Detailed Bulletin Analysis

    The surveillance of waterborne enteric pathogens in Epidemiological Week 20 has flagged a significant clinical concern, with Typhoid fever cases recorded at 126 and Bloody Diarrhoea cases totaling 783. Enteric disease transmission remains a persistent threat, particularly in urban and peri-urban locations with compromised water and sanitation systems. To address these threats, the National IDSR recommendations explicitly target several high-reporting districts—specifically Kasungu, Dedza, Blantyre, Lilongwe, and Mchinji—requiring immediate field investigations to identify the contamination sources driving these persistent Typhoid fever clusters.

    When compared to the baseline figures from Epidemiological Week 17, both enteric indicators demonstrate a highly concerning escalation in transmission. Typhoid fever cases more than doubled, experiencing an extraordinary 117.2% surge from 58 cases in Week 17 to 126 cases in Week 20. Bloody Diarrhoea cases also followed a highly concerning upward trend, rising by 26.3% from 620 cases to 783 cases. This rapid rise across multiple enteric indicators confirms that waterborne and foodborne pathogens are actively spreading, requiring a swift shift from passive clinical tracking to active environmental health interventions.

    Based on these findings, we recommend that Kasungu, Dedza, Blantyre, Lilongwe, and Mchinji DHOs deploy rapid response teams to conduct systematic water quality monitoring and food safety inspections. Stool and blood cultures must be collected from all suspected Typhoid cases to check for potential antibiotic resistance patterns and guide precise clinical therapy. Furthermore, environmental health officers must implement localized water treatment protocols, distribute household water-guard chlorine solution, and conduct extensive hygiene sensitization campaigns in high-density markets and informal settlements to break the transmission chains.

    III. Critical Alerts & Mortality

    Cholera and Mpox Status

    Detailed Bulletin Analysis

    Epidemiological Week 20 recorded a highly active Cholera situation, with 145 suspected cases resulting in 84 laboratory-confirmed cholera cases, alongside a commendable zero-death record. This stable survival rate reflects the high quality of supportive rehydration and prompt case management within established Cholera Treatment Units (CTUs). On the zoonotic disease front, Mpox surveillance detected 2 suspect alerts, but happily, zero (0) new cases were confirmed, keeping the cumulative national total stable at 157 confirmed cases since the outbreak began in April 2025.

    A comparison with Epidemiological Week 17 shows that the Cholera outbreak is evolving toward a highly concentrated phase with a much higher laboratory-confirmation rate. While the absolute number of suspected cholera cases declined from 255 in Week 17 to 145 in Week 20 (a 43.1% reduction), the confirmed cholera cases surged dramatically from 25 in Week 17 to 84 in Week 20 (a 236% increase). This massive surge in confirmed cases indicates that transmission is highly concentrated in hotspot districts, particularly Blantyre (180 cumulative cases) and Chikwawa (144 cumulative cases). Concurrently, Mpox alerts rose from zero to 2, though zero new cases were confirmed.

    To counter this growing Cholera threat, the National Incident Management System must continue to direct emergency water, sanitation, and hygiene (WASH) resources to high-incidence hotspots. In addition, CTU inventories of Oral Rehydration Salts (ORS), IV fluids, and rapid cholera tests must be restocked to prevent shortages. While Mpox reported zero confirmed cases, the 2 new alerts must be investigated within 24 hours. Cross-border coordination with Mozambique and Tanzania must also be maintained to make sure any imported cases are detected and managed promptly.

    SARI & Respiratory Mortality

    Detailed Bulletin Analysis

    Severe Acute Respiratory Infections (SARI) presented 166 clinical cases and 2 deaths during Epidemiological Week 20. The severe respiratory burden continues to affect several central districts, with Kamuzu Central Hospital (KCH) in Lilongwe reporting 49 cases and Dowa DHO reporting 41 cases. This consistent concentration highlights the need for continuous sentinel respiratory surveillance and clinical preparedness within tertiary facilities to handle sudden influxes of acute respiratory cases.

    When evaluated against the baseline from Epidemiological Week 17, the SARI surveillance data displays a notable increase in respiratory morbidity and mortality. National SARI cases rose by 55.1%, climbing from 107 cases in Week 17 to 166 cases in Week 20, while SARI-associated deaths increased from 1 to 2. This upward trend in both clinical cases and fatal outcomes suggests the potential circulation of highly contagious seasonal respiratory pathogens, such as Influenza A/B or RSV, requiring immediate diagnostic and clinical attention.

    We recommend that clinical teams at Kamuzu Central Hospital, Dowa District Hospital, and other sentinel hospitals continue to systematically collect nasopharyngeal swabs from SARI patients for PCR diagnostic analysis. Healthcare facilities must ensure that pediatric oxygen delivery systems, clinical nebulizers, and essential respiratory therapeutics remain fully functional. Furthermore, clinicians must continue to document and report SARI cases on the OHSP, allowing public health teams to identify and respond to any new respiratory anomalies quickly.

    IV. Vaccine Preventable Diseases

    Measles & VPD Surveillance Distribution

    Detailed Bulletin Analysis

    Vaccine-Preventable Disease (VPD) surveillance remains a high-priority public health activity, with cumulative confirmed Measles cases rising significantly to 366 across 23 districts in 2026. This week recorded 108 new Measles alerts, emphasizing the persistent transmission risk in hotspot districts, with Balaka reporting the highest proportion at 21.9% (80 cumulative cases). Under the IDSR framework, Acute Flaccid Paralysis (AFP) surveillance recorded 3 cases, and Meningococcal meningitis recorded 7 cases, highlighting the need for sustained immunization coverage and active case searching.

    When compared to Epidemiological Week 17, the VPD surveillance profile displays a highly concerning escalation in Measles transmission. Weekly Measles alerts more than doubled, experiencing an extraordinary 157.1% surge from 42 cases in Week 17 to 108 cases in Week 20. The cumulative confirmed Measles cases rose from 287 to 366, showing active transmission across multiple districts. Conversely, weekly AFP alerts remained relatively stable, moving from 2 to 3, which reflects normal baseline surveillance sensitivity, while suspected Meningococcal meningitis cases remained stable at 7.

    We recommend that the Expanded Programme on Immunisation (EPI) immediately schedules targeted supplemental immunization activities (SIA) in Balaka and other high-burden districts to interrupt Measles transmission. For the 3 reported AFP cases, district coordinators must ensure that dual stool samples are collected and sent to the laboratory under strict cold chain conditions. To prevent further Measles spread, healthcare facilities must strengthen routine immunization coverage, conduct active case searches in communities, and ensure immediate diagnostic sample collection.

    V. Summary of Recommendations

    1. Reporting Quality & District Targets

    Zomba, Dowa, and Karonga DHOs must implement immediate data validation procedures to improve completeness and timeliness back to target levels of 80% or greater, while Mzuzu Central Hospital must improve on timeliness.

    2. Typhoid Field Investigations

    Kasungu, Dedza, Blantyre, Lilongwe, and Mchinji DHOs must conduct immediate, comprehensive field investigations in the catchment areas of high-reporting clinics to identify the waterborne or foodborne sources of these enteric clusters.

    3. AEFI Safety Investigation

    Mzimba North DHO is directed to perform a detailed vaccine safety investigation on the reported Adverse Events Following Immunization (AEFI) to maintain high community trust in routine childhood immunizations.

    Official Documentation

    Access the full PDF bulletin for Epidemiological Week 20, 2026, including detailed district-level performance tables and annexes.

    Authored & Published By

    Moses Nyambalo Phiri

    Public Health Institute of Malawi

    Ministry of Health, Republic of Malawi